Molecular engineering of Ghfp, the gonococcal orthologue of neisseria meningitidis factor H binding protein

Clinical and Vaccine Immunology

Volumn 22, Issue 7, 2015, Pages 769-777

  Rippa, Valentina ^a   Santini, Laura ^a   Surdo, Paola Lo ^a   Cantini, Francesca ^b   Veggi, Daniele ^a   Gentile, Maria Antonietta ^a   Grassi, Eva ^a   Iannello, Giulia ^a   Brunelli, Brunella ^a   Ferlicca, Francesca ^a   Palmieri, Emiliano ^a   Pallaoro, Michele ^a   Aricò, Beatrice ^a   Banci, Lucia ^b   Pizza, Mariagrazia ^a   Scarselli, Maria ^a  

^a GSK   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIAL VACCINE; BACTERIUM ANTIBODY; CHIMERIC PROTEIN; EPITOPE; FACTOR H BINDING PROTEIN; GONOCOCCAL HOMOLOGUE OF FHBP PROTEIN; NG 5 2 PROTEIN; NG 5 6 PROTEIN; NG 5 8 PROTEIN; UNCLASSIFIED DRUG; FACTOR H-BINDING PROTEIN, NEISSERIA MENINGITIDIS; HYBRID PROTEIN; RECOMBINANT VACCINE; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIGENICITY; ARTICLE; BACTERIAL STRAIN; BINDING AFFINITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SEQUENCE; EPITOPE MAPPING; FEMALE; GENETIC ENGINEERING; GENETIC VARIABILITY; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION PREVENTION; MENINGOCOCCOSIS; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; VACCINATION; ANIMAL; BLOOD; GENETICS; IMMUNOLOGY; NEISSERIA GONORRHOEAE; PROTEIN ENGINEERING; SEQUENCE HOMOLOGY; SERUM BACTERICIDAL ACTIVITY;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; BLOOD BACTERICIDAL ACTIVITY; MICE; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; VACCINES, SYNTHETIC; VIRULENCE FACTORS;

EID: 84936852778     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00794-14     Document Type: Article

References (40)

1. Jafri RZ, Ali A, Messonnier NE, Tevi-Benissan C, Durrheim D, Eskola J, Fermon F, Klugman KP, Ramsay M, Sow S, Zhujun S, Bhutta ZA, Abramson J. 2013. Global epidemiology of invasive meningococcal disease. Popul Health Metr 11:17. http://dx.doi.org/10.1186/1478-7954-11-17.
2. Zimmer SM, Stephens DS. 2004. Meningococcal conjugate vaccines. Expert Opin Pharmacother 5:855-863. http://dx.doi.org/10.1517/14656566.5.4.855.
3. Dull PM, McIntosh ED. 2012. Meningococcal vaccine development-from glycoconjugates against MenACWY to proteins against MenB-potential for broad protection against meningococcal disease. Vaccine 30(Suppl 2):B18-B25. http://dx.doi.org/10.1016/j.vaccine.2012.01.062.
4. Marshall HS, Richmond PC, Nissen MD, Jiang Q, Anderson AS, Jansen KU, Reynolds G, Ziegler JB, Harris SL, Jones TR, Perez JL. 2012. Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-controlled clinical trial. Pediatr Infect Dis J 31:1061-1068. http://dx.doi.org/10.1097/INF.0b013e31826327e4.
5. Nissen MD, Marshall HS, Richmond PC, Jiang Q, Harris SL, Jones TR, Jansen KU, Perez JL. 2013. A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents. Pediatr Infect Dis J 32:364-371. http://dx.doi.org/10.1097/INF.0b013e31827b0d24.
6. Esposito S, Castellazzi L, Bosco A, Musio A, Stoddard J. 2014. Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis prevention. Immunotherapy 6:395-408. http://dx.doi.org/10.2217/imt.14.11.
7. Lucidarme J, Tan L, Exley RM, Findlow J, Borrow R, Tang CM. 2011. Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein. Clin Vaccine Immunol 18:1002-1014. http://dx.doi.org/10.1128/CVI.00055-11.
8. Masignani V, Comanducci M, Giuliani MM, Bambini S, Adu-Bobie J, Arico B, Brunelli B, Pieri A, Santini L, Savino S, Serruto D, Litt D, Kroll S, Welsch JA, Granoff DM, Rappuoli R, Pizza M. 2003. Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J Exp Med 197:789-799. http://dx.doi.org/10.1084/jem.20021911.
9. Fletcher LD, Bernfield L, Barniak V, Farley JE, Howell A, Knauf M, Ooi P, Smith RP, Weise P, Wetherell M, Xie X, Zagursky R, Zhang Y, Zlotnick GW. 2004. Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infect Immun 72:2088-2100. http://dx.doi.org/10.1128/IAI.72.4.2088-2100.2004.
10. Richmond PC, Nissen MD, Marshall HS, Lambert SB, Roberton D, Gruber WC, Jones TR, Arora A. 2012. A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trial. Vaccine 30:6163-6174. http://dx.doi.org/10.1016/j.vaccine.2012.07.065.
11. Giuliani MM, Adu-Bobie J, Comanducci M, Arico B, Savino S, Santini L, Brunelli B, Bambini S, Biolchi A, Capecchi B, Cartocci E, Ciucchi L, Di Marcello F, Ferlicca F, Galli B, Luzzi E, Masignani V, Serruto D, Veggi D, Contorni M, Morandi M, Bartalesi A, Cinotti V, Mannucci D, Titta F, Ovidi E, Welsch JA, Granoff D, Rappuoli R, Pizza M. 2006. A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci U S A 103:10834-10839. http://dx.doi.org/10.1073/pnas.0603940103.
12. Madico G, Welsch JA, Lewis LA, McNaughton A, Perlman DH, Costello CE, Ngampasutadol J, Vogel U, Granoff DM, Ram S. 2006. The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factorHand enhances serum resistance. J Immunol 177:501-510. http://dx.doi.org/10.4049/jimmunol.177.1.501.
13. Schneider MC, Exley RM, Chan H, Feavers I, Kang YH, Sim RB, Tang CM. 2006. Functional significance of factor H binding to Neisseria meningitidis. J Immunol 176:7566-7575. http://dx.doi.org/10.4049/jimmunol.176.12.7566.
14. Scarselli M, Arico B, Brunelli B, Savino S, Di Marcello F, Palumbo E, Veggi D, Ciucchi L, Cartocci E, Bottomley MJ, Malito E, Lo Surdo P, Comanducci M, Giuliani MM, Cantini F, Dragonetti S, Colaprico A, Doro F, Giannetti P, Pallaoro M, Brogioni B, Tontini M, Hilleringmann M, Nardi-Dei V, Banci L, Pizza M, Rappuoli R. 2011. Rational design of a meningococcal antigen inducing broad protective immunity. Sci Transl Med 3:91ra62. http://dx.doi.org/10.1126/scitranslmed.3002234.
15. Jongerius I, Lavender H, Tan L, Ruivo N, Exley RM, Caesar JJ, Lea SM, Johnson S, Tang CM. 2013. Distinct binding and immunogenic properties of the gonococcal homologue of meningococcal factor H binding protein. PLoS Pathog 9:e1003528. http://dx.doi.org/10.1371/journal.ppat.1003528.
16. Veggi D, Gentile MA, Cantini F, Lo Surdo P, Nardi-Dei V, Seib KL, Pizza M, Rappuoli R, Banci L, Savino S, Scarselli M. 2012. The factor H binding protein of Neisseria meningitidis interacts with xenosiderophores in vitro. Biochemistry 51:9384-9393. http://dx.doi.org/10.1021/bi301161w.
17. Johnson S, Tan L, van der Veen S, Caesar J, Goicoechea De Jorge E, Harding RJ, Bai X, Exley RM, Ward PN, Ruivo N, Trivedi K, Cumber E, Jones R, Newham L, Staunton D, Ufret-Vincenty R, Borrow R, Pickering MC, Lea SM, Tang CM. 2012. Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules. PLoS Pathog 8:e1002981. http://dx.doi.org/10.1371/journal.ppat.1002981.
18. Cendron L, Veggi D, Girardi E, Zanotti G. 2011. Structure of the uncomplexed Neisseria meningitidis factor H binding protein fHbp (rLP2086). Acta Crystallogr Sect F Struct Biol CrystCommun67:531-535. http://dx.doi.org/10.1107/S1744309111006154.
19. Schneider MC, Prosser BE, Caesar JJ, Kugelberg E, Li S, Zhang Q, Quoraishi S, Lovett JE, Deane JE, Sim RB, Roversi P, Johnson S, Tang CM, Lea SM. 2009. Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature 458:890-893. http://dx.doi.org/10.1038/nature07769.
20. Cantini F, Savino S, Scarselli M, Masignani V, Pizza M, Romagnoli G, Swennen E, Veggi D, Banci L, Rappuoli R. 2006. Solution structure of the immunodominant domain of protective antigen GNA1870 of Neisseria meningitidis. J Biol Chem 281:7220-7227. http://dx.doi.org/10.1074/jbc.M508595200.
21. Beernink PT, Welsch JA, Bar-Lev M, Koeberling O, Comanducci M, Granoff DM. 2008. Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor H binding protein. Infect Immun 76:4232-4240. http://dx.doi.org/10.1128/IAI.00367-08.
22. Giuliani MM, Santini L, Brunelli B, Biolchi A, Aric? B, Di Marcello F, Cartocci E, Comanducci M, Masignani V, Lozzi L, Savino S, Scarselli M, Rappuoli R, Pizza M. 2005. The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies. Infect Immun 73:1151-1160. http://dx.doi.org/10.1128/IAI.73.2.1151-1160.2005.
23. Scarselli M, Cantini F, Santini L, Veggi D, Dragonetti S, Donati C, Savino S, Giuliani MM, Comanducci M, Di Marcello F, Romagnoli G, Pizza M, Banci L, Rappuoli R. 2009. Epitope mapping of a bactericidal monoclonal antibody against the factor H binding protein of Neisseria meningitidis. J Mol Biol 386:97-108. http://dx.doi.org/10.1016/j.jmb.2008.12.005.
24. Faleri A, Santini L, Brier S, Pansegrau W, Lo Surdo P, Scarselli M, Buricchi F, Volpini G, Genovese A, van der Veen S, Lea S, Tang CM, Savino S, Pizza M, Finco O, Norais N, Masignani V. 2014. Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factorHbinding protein but have different functional properties. FASEB J 28:1644-1653. http://dx.doi.org/10.1096/fj.13 -239012.
25. Malito E, Faleri A, Lo Surdo P, Veggi D, Maruggi G, Grassi E, Cartocci E, Bertoldi I, Genovese A, Santini L, Romagnoli G, Borgogni E, Brier S, Lo Passo C, Domina M, Castellino F, Felici F, van der Veen S, Johnson S, Lea SM, Tang CM, Pizza M, Savino S, Norais N, Rappuoli R, Bottomley MJ, Masignani V. 2013. Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen. Proc Natl Acad Sci U S A 110:3304-3309. http://dx.doi.org/10.1073/pnas.1222845110.
26. Welsch JA, Rossi R, Comanducci M, Granoff DM. 2004. Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine. J Immunol 172:5606-5615. http://dx.doi.org/10.4049/jimmunol.172.9.5606.
27. Cantini F, Veggi D, Dragonetti S, Savino S, Scarselli M, Romagnoli G, Pizza M, Banci L, Rappuoli R. 2009. Solution structure of the factor H binding protein, a survival factor and protective antigen of Neisseria meningitidis. J Biol Chem 284:9022-9026. http://dx.doi.org/10.1074/jbc.C800214200.
28. Karlsson R, Katsamba PS, Nordin H, Pol E, Myszka DG. 2006. Analyzing a kinetic titration series using affinity biosensors. Anal Biochem 349: 136-147. http://dx.doi.org/10.1016/j.ab.2005.09.034.
29. Borrow R, Aaberge IS, Santos GF, Eudey TL, Oster P, Glennie A, Findlow J, H?iby EA, Rosenqvist E, Balmer P, Martin D. 2005. Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup B, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine. Clin Diagn Lab Immunol 12:970-976. http://dx.doi.org/10.1128/CDLI.12.8.970-976.2005.
30. Vogel U, Taha M-K, Vazquez JA, Findlow J, Claus H, Stefanelli P, Caugant DA, Kriz P, Abad R, Bambini S, Carannante A, Deghmane AE, Fazio C, Frosch M, Frosi G, Gilchrist S, Giuliani MM, Hong E, Ledroit M, Lovaglio PG, Lucidarme J, Musilek M, Muzzi A, Oksnes J, Rigat F, Orlandi L, Stella M, Thompson D, Pizza M, Rappuoli R, Serruto D, Comanducci M, Boccadifuoco G, Donnelly JJ, Medini D, Borrow R. 2013. Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis 13:416 - 425. http://dx.doi.org/10.1016/S1473-3099(13)70006-9.
31. Bambini S, Piet J, Muzzi A, Keijzers W, Comandi S, De Tora L, Pizza M, Rappuoli R, van de Beek D, van der Ende A, Comanducci M. 2013. An analysis of the sequence variability of meningococcal fHbp, NadA and NHBAover a 50-year period in the Netherlands. PLoS One 8:e65043. http://dx.doi.org/10.1371/journal.pone.0065043.
32. Davies DR, Cohen GH. 1996. Interactions of protein antigens with antibodies. Proc Natl Acad Sci U S A 93:7-12. http://dx.doi.org/10.1073/pnas.93.1.7.
33. Rubinstein ND, Mayrose I, Halperin D, Yekutieli D, Gershoni JM, Pupko T. 2008. Computational characterization of B-cell epitopes. Mol Immunol 45:3477-3489. http://dx.doi.org/10.1016/j.molimm.2007.10.016.
34. Chakrabarti P, Janin J. 2002. Dissecting protein-protein recognition sites. Proteins 47:334-343. http://dx.doi.org/10.1002/prot.10085.
35. Azoitei ML, Correia BE, Ban YE, Carrico C, Kalyuzhniy O, Chen L, Schroeter A, Huang PS, McLellan JS, Kwong PD, Baker D, Strong RK, Schief WR. 2011. Computation-guided backbone grafting of a discontinuous motif onto a protein scaffold. Science 334:373-376. http://dx.doi.org/10.1126/science.1209368.
36. Azoitei ML, Ban YE, Julien JP, Bryson S, Schroeter A, Kalyuzhniy O, Porter JR, Adachi Y, Baker D, Pai EF, Schief WR. 2012. Computational design of high-affinity epitope scaffolds by backbone grafting of a linear epitope. J Mol Biol 415:175-192. http://dx.doi.org/10.1016/j.jmb.2011.10.003.
37. Correia BE, Ban YE, Friend DJ, Ellingson K, Xu H, Boni E, Bradley-Hewitt T, Bruhn-Johannsen JF, Stamatatos L, Strong RK, Schief WR. 2011. Computational protein design using flexible backbone remodeling and resurfacing: case studies in structure-based antigen design. J Mol Biol 405:284-297. http://dx.doi.org/10.1016/j.jmb.2010.09.061.
38. Seib KL, Brunelli B, Brogioni B, Palumbo E, Bambini S, Muzzi A, DiMarcello F, Marchi S, van der Ende A, Arico B, Savino S, Scarselli M, Comanducci M, Rappuoli R, Giuliani MM, Pizza M. 2011. Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies. Infect Immun 79:970-981. http://dx.doi.org/10.1128/IAI.00891-10.
39. Combet C, Blanchet C, Geourjon C, Deleage G. 2000. NPS@: network protein sequence analysis. Trends Biochem Sci 25:147-150. http://dx.doi.org/10.1016/S0968-0004(99)01540-6.
40. Dereeper A, Guignon V, Blanc G, Audic S, Buffet S, Chevenet F, Dufayard JF, Guindon S, Lefort V, Lescot M, Claverie JM, Gascuel O. 2008. Phylogeny. Fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res 36:W465-W469. http://dx.doi.org/10.1093/nar/gkn180.